Skip to main content
. Author manuscript; available in PMC: 2013 Aug 12.
Published in final edited form as: Ther Drug Monit. 2008 Oct;30(5):620–627. doi: 10.1097/FTD.0b013e318185813d

Figure 3.

Figure 3

Mass chromatograms of blank plasma, 0.3 nM lenalidomide and flavopiridol (LLOQ), or 1 nM lenalidomide (LLOQ) and flavopiridol. Single reaction monitoring channels include lenalidomide (260.06 > 149.10), flavopiridol (402.09 > 341.02), and genistein (271.09 > 152.90).